Xenetic Biosciences (XBIO) Change in Accured Expenses (2023 - 2025)
Xenetic Biosciences (XBIO) has disclosed Change in Accured Expenses for 6 consecutive years, with $208345.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Change in Accured Expenses rose 136.03% year-over-year to $208345.0, compared with a TTM value of $102368.0 through Sep 2025, up 273.24%, and an annual FY2024 reading of $84678.0, up 132.13% over the prior year.
- Change in Accured Expenses was $208345.0 for Q3 2025 at Xenetic Biosciences, down from $235503.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $871108.0 in Q2 2024 and bottomed at -$578195.0 in Q3 2024.
- Average Change in Accured Expenses over 3 years is $3510.8, with a median of -$93091.0 recorded in 2024.
- Peak annual rise in Change in Accured Expenses hit 5726.81% in 2024, while the deepest fall reached 393.23% in 2024.
- Year by year, Change in Accured Expenses stood at -$258912.0 in 2023, then soared by 55.53% to -$115144.0 in 2024, then soared by 280.94% to $208345.0 in 2025.
- Business Quant data shows Change in Accured Expenses for XBIO at $208345.0 in Q3 2025, $235503.0 in Q2 2025, and -$226336.0 in Q1 2025.